• Poster

Comparative Budget Impact of Formulary Inclusion of Zoledronic Acid and Denosumab for Prevention of Skeletal-Related Events in Patients With Bone Metastases

Citation

Bell, M. J., Miller, J. D., Namjoshi, M., & Russell, M. W. (2011, May). Comparative Budget Impact of Formulary Inclusion of Zoledronic Acid and Denosumab for Prevention of Skeletal-Related Events in Patients With Bone Metastases. Presented at ISPOR 16th Annual International Meeting, .

Abstract